公司资料
Theseus Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- THRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for THRX.
公司概览
业务概览
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy. The company aims to build differentiated assets in genetically defined tumors.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Theseus sits in specialty oncology biotechnology.
商业模式特征
The business depends on clinical proof, target selectivity, and the ability to create a focused oncology franchise.
生物医药行业定位
Theseus is a small-cap oncology catalyst name where early data can materially reshape the story.
未来催化剂
- Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward. The company still needs a clearer development road map.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。